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1. Introduction 
Several drugs known to interact with nucleic acids 
through intercalation such as ethidium bromide, 
actinomycin D, daunomycin or mithramycin have a 
strong inhibitory effect on the growth of micro- 
organisms and eukaryotic ells [1-3].  These cytotoxic 
properties were probably result from the interaction 
of these drugs with nucleic acids or modifications of 
other metabolic process or synthesis. 
The ellipticines (dimethyl-5-11 [6 H]-pyrido 
[4-3-b] carbazoles) are heterocyclic compounds also 
able to intercalate into DNA [4,5]. In this series, 
9-hydroxyellipticine (fig. 1) which displays a high 
affinity for DNA has been thoroughly investigated 
[6]. This compound is very active against L1210 
mice lymphoid leukemia [7]. 
As a preliminary attempt to comprehend the 
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Fig. t. Chemical structure of 9-hydroxyellipticine. 
mechanism of actions of this drug, we report here the 
kinetics of several of its effects on the growth and 
macromolecular biosynthesis of Escherichia coli 
K 12. Pronounced and immediate ffect on the 
growth and viability were found depending both on 
the drug and extracellular magnesium ion concentra- 
tion. RNA and protein synthesis were found to be 
inhibited while DNA synthesis was only slightly 
reduced. 
2. Materials and methods 
2.1. Bacterial strains and media 
E. Coli CR 341 (F-, thy A, thi, leu, thr, met, 
lacy A, str A) a K 12 strain was used in this study. 
The cells were grown in a modified Cohen and 
Richenberg medium [8] of the following composi- 
tion (g/l): (NH4)2SO4, 2.0; FeSO4.H20, 0.0005; 
KC1, 0.075; Nail2 POa" H2 O, 0.138; and triethanol- 
amine, 7.5. The pH was adjusted to 7.8 with HC1. 
This mineral medium was supplemented for growth 
with 0.5% sodium succinate and with the required 
amino acids (100 ~g/ml of each), thymine (I00/ag/ml 
or 10/~g/ml for incorporation studies with the labeled 
precursor) and thiamine (50/lg/ml). The concentra- 
tion of Mg ++ critical in these experiments was ajusted 
to a final value of 10 -4 M unless otherwise stated. 
2.2. Culture condit ions 
Inocula were grown overnight at 37°C and then 
diluted 20-fold in the same medium. Cultures were 
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grown at 37°C in erlenmeyer flasks on a rotary 
shaker and" the growth was followed by measuring the 
turbidity at 578 nm with an Eppendorf photometer. 
In that case the drug was added in the mid exponential 
phase. Survival experiments were performed on 
samples diluted to 3.10 -s in mineral medium and 
were plated on complete drug-free agar medium. 
2.3. Synthesis of cellular macromolecules 
In order to detect changes in the rate of macro- 
molecular syntheses, radioactive precursors were 
added at the same time as 9-hydroxyellipticine. 
Protein synthesis was followed by measuring the 
incorporation of [S4C]leucine after precipitation of 
bacteria by 10% cold trichloroacetic a id and filtration 
on Millipore HAWP (0.45 tam) filters. The dry filters 
were counted in Toluene-PPO-POPOP scintillation 
liquid with a Packard Tric-Carb liquid scintillation 
spectrometer. RNA and DNA synthesis were followed 
by measuring the incorporation of [3H]uracil 
(final concentration, 50 tag/ml) and [3H]thymine 
(final concentration, 10 tag/ml) into cold trichloracetic 
acid-precipitable material. 
2.4. Determination of  the nucleotide pool 
The incorporation of 32po3- into ATP, GTP and 
ppGpp was measured in the medium described above 
but with a low phosphate concentration (0.1 mM). 
Nucleotides were determined according to Cashel 
et al. [9,10] by thin-layer chromatography on poly- 
ethyleneimine-cellulose f the material soluble in 1 M 
cold formic acid were performed. The solvent was 
either 0.8 M or 1.5 M KH2PO4, 
2.5. Reagents 
9-hydroxyellipticine was synthesized in our 
laboratory according to Dalton et al. [11] and was a 
generous gift of M. Lecointe. Its structure was 
ascertained by nuclear magnetic resonance and mass 
spectroscopy, and elemental nalysis. Its purity was 
checked routinely by thin layer chromatography and 
U.V. spectrophotometry. Labelled phosphoric acid; 
[14C] leucine (240 mCi/mmole); [3H]uracil 
(22 Ci/mmole) and [3H] thymine (25 Ci/mmole) were 
products of the Commissariat ~ l'Energie Atomique, 
Saclay, France. The polyethyleneimine-cellulose 
sheets were from Macherey-Nagel (Dtiren, Germany). 
Reagent grade chemicals were used throughout. 
3. Results and discussion 
3.1. Effect on growth and viability 
The overall effects of various concentrations of 
9-hydroxye]lipticine on the growth and viability of 
E. coli strain CR 341 are shown in fig.2. Cell growth 
(measured turbidimetrically) was slowed immediately 
after addition of the drug and remain exponential for 
generations. The inhibitory effect was linearly propor- 
tional to the concentration f drug added and was 
complete when this concentration exceeded 25 taM. 
9-Hydroxyellipticine had a bacteriostatic effect on 
E. coli when its concentration was less than 15 taM. 
Under these conditions the number of viable cells 
remained constant after two hours of incubation in 
the presence of the drug. When 9-hydroxyellipticine- 
treated cells were filtered, washed and quickly 
immersed in fresh prewarmed medium, growth 
resumed quite immediately reaching balanced con- 
ditions within some minutes. 
For concentrations higher than 15 taM there was 
a rapid decrease in viable counts depending on the 
time of incubation with the drug. For concentrations 
of 9-hydroxyellipticine of 25 taM, there is an almost 
complete loss of colony forming ability after two 
hours of treatment. 
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Fig.2. Effect of 9-hydroxyellipticine o  the growth rate (e) 
and the viability (o) of E. Coli CR 341. The growth medium 
used is described under Materials and methods. The viability 
was determined byplating dilution on broth agar 2 h after 
addition of the drug. 
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Fig.3. Reduction of growth rate ofE. ColiCR 341 by 15 #M 
of 9-hydroxyelliptici~e as a function of Mg ++ concentration 
(o -e )  10 raM; (o-c7) 1 mM; (= m) 0.1 raM; (o -o )  0.01 mM 
Mg ~. The inset shows the determinations of K M of Mg ++ for 
growth process in the presence of  9-hydroxyellipticine. #0 
is the growth rate before addition of the drug (generations 
per hour); ~ is the growth rate in the presence of the drug. 
3.2. Mg +÷ and growth inhibitory effect of 
9-hydroxyelliptieine 
9-Hydroxyellipticine (15/aM) completely inhibited 
the growth ofE. Coli CR 341 in the presence of 10/aM 
Mg +~ but the growth rate was not reduced when Mg ~+ 
was raised to 10 mM (fig.3). Moreover, raising the Mg ÷÷ 
concentration subsequent to 9-hydroxyellipticine inhi- 
bition allowed the culture to resume growth provided 
no loss of viability had occurred. When 9-hydroxy- 
ellipticine was 15/aM the Mg ÷÷ concentration 
required for half maximal growth was 0.2 mM (fig.3, 
insert). For untreated/L Coli cells this effect occurs 
when the Mg ~ concentration is around 1/aM [12]. 
The relationship between growth inhibition by a 
given concentration of 9-hydroxyellipticine and the 
external Mg ++ ions concentration suggests a sort of 
competitive inhibition between 9-hydroxyellipticine 
and one of the numerous processes required for 
growth and involving Mg ++. It does not rule out the 
simple explanation that the penetration of the drug 
across the outer membrane ofE. Coli is prevented by 
Mg ~ ions closely bound to this structure. 
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Fig.4. Effect of  9-hydroxyellipticine on the accumulation of ATP (o), GTP (e) and ppGpp (n) in E. Coli CR 341. An exponential 
growing culture (6 ml) in succinate medium was labeled with 32PO 4 (around 200 uCi) for 45 rain before 9-hydroxycellipticine 
(20/aM) was added. Nucleotides were extracted and measured as described in Materials and methods. 
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3.3. Eff'ects on triphosphoribonucleotides andppGpp 
The kinetics of 32po 4 labeling of purine nucleotides 
were followed upon addition of the drug. The level of 
ATP and GTP (rigA) and CTP (data not shown) 
increase rapidly as soon as the drug was added and 
reached values about twice higher than the control 
ones. The level of the unusual guanosine nucleotide 
which accumulates during the stringent responses 
[9,10,13,14] did not increase over the control evels 
after drugs addition. 
3.4. Effects on macromolecule synthesis 
The addition of 9-hydroxyellipticine (12/aM) to a 
culture of/z: coli CR 341 growing exponentially in a 
succinate medium resulted in an immediate 40% 
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inhibition of the rate of [14C]leucine and [3H] uracil 
incorporation respectively into protein and RNA 
(fig.5). DNA elongation was much less affected and 
continue at about 80% of its initial velocity. When the 
concentration of 9-hydroxyellipticine reached 20/aM 
the incorporation of each precursor was completely 
stopped. In the above experiments, ynthesis was 
followed by measuring the incorporation of radio- 
active precursors into acid insoluble material in an 
auxotroph (except for uracil). Different mechanisms 
of action can account for the observed effects: (a) 
interference with transport of the added precursor in 
relation to membrane permeability, (b) inhibition of 
respiration, (c) inhibition of the synthesis of ribo- 
nucleotides triphosphates, (d) degradation of RNA or 
(e) direct inhibition of the polymerizing systems. It is 
unlikely that 9-hydroxyellipticine inhibits the synthesis 
of ribonucleotides triphosphates since the action of the 
drug was accompanied by an increase in the content 
of nucleic acids precursors. It is also unlikely that the 
formation of aminoacids i affected since the drug did 
not induce the stringent response. However it 
appeared that no specific inhibition for RNA and 
protein synthesis occurs since the rate of precursors 
incorporation i these macromolecules are identical. 
Interestingly, drugs in the ellipticine series have been 
shown to decrease the rate of oxygen consumption 
in yeast (Pinto and Paoletti, unpublished results). 
Such an inhibition of respiration could also explain 
the effects presently observed on bacteria. Work is in 
progress to delineate between some of the other 
possibilities. 
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